The SLC46A1 gene helps your gut absorb folate, a form of vitamin B9, and move it to places that need it, including the brain. If this gene does not work well, folate levels can become very low, which may lead to anemia, poor growth, diarrhea, repeated infections, or seizures and developmental problems in infancy. This gene plays an important role in keeping fast-growing tissues healthy, especially blood, immune cells, and the nervous system.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or managing activities in the body. Some genes provide the directions to produce proteins, which are the parts of cells that do much of the work. Others mostly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence your response to food, stress, and medicines. For a deeper look at this subject, more information is available in LearnHub.
Overview
SLC46A1Gene function
What if the gene works
The SLC46A1 gene helps move folate, a form of vitamin B9, from food into the body and into some cells. This helps support normal blood cell production, growth, and brain function.
Risk
What if the gene does not work
When the SLC46A1 gene does not work properly, the body cannot absorb and move folate effectively, causing hereditary folate malabsorption. Effects can range from milder to more severe, often involving anemia, poor growth, infections, and neurologic problems.
Treatment
What does that mean for your treatment
Pathogenic variants in the SLC46A1 gene usually shift treatment toward folinic acid rather than standard folic acid, which may not work well enough. Many people need higher doses, and some need injections, to support blood levels and the nervous system.
Conditions associated with SLC46A1
Gene function
What if the gene works
Your body uses folate, a B vitamin, to make new DNA and support fast-growing cells. A key part of how the SLC46A1 gene helps absorb folate is moving it from food into the body, especially in the small intestine. It also helps deliver folate to the fluid around the brain and spinal cord. This steady transport supports normal cell growth and daily tissue renewal.
The SLC46A1 gene gives cells instructions for a folate transporter in the upper small intestine. That transporter absorbs folate from food in the mildly acidic environment near the gut lining.
Its protein carries folate across cell membranes so it can enter the bloodstream and reach tissues. This helps keep a steady supply available for everyday jobs like making DNA.
The SLC46A1 gene also helps move folate into the fluid around the brain and spinal cord. This supports a dependable folate supply for the nervous system.
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and can contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC46A1 gene can weaken or block the cell’s folate transporter by changing its shape, reducing its stability, or keeping it from reaching the cell surface. More disruptive changes, including variants that truncate the protein or disrupt splicing, often leave little or no transport activity, while some missense variants retain partial function. In hereditary folate malabsorption, this spectrum of how SLC46A1 gene variants affect folate transport can influence how early features appear and how pronounced they are.
How variants are linked to conditions
Inheriting two pathogenic variants in the SLC46A1 gene causes hereditary folate malabsorption, a rare inherited condition. This diagnosis is typically linked to very low folate levels with anemia, diarrhea, poor growth, frequent infections, and sometimes seizures or developmental delay, often starting in infancy.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC46A1, risk is mainly set by the variants inherited at birth rather than by lifestyle. The chance is higher when both parents carry a harmful SLC46A1 variant, and it can also be higher in families with blood relatives having children together. There is not enough evidence to say diet, supplements, or everyday habits change this inherited risk.
Inheritance of SLC46A1 variants
Variants in the SLC46A1 gene are inherited in an autosomal recessive pattern. This means a child usually needs to inherit one changed copy from each parent to have SLC46A1-related hereditary folate malabsorption. Parents who each carry one variant are often unaffected carriers, and with each pregnancy there is a 25% chance the child will inherit both changed copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This is the usual pattern described when explaining how SLC46A1 gene variants are inherited.
What does my SLC46A1 result mean for my family?
Changes in the SLC46A1 gene are linked to a rare inherited condition called hereditary folate malabsorption, which usually runs in families in a recessive pattern. For family members, this often means parents may be healthy carriers, and brothers or sisters could also have the condition or be carriers. Other relatives may also carry the gene change, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
To find out about changes in the SLC46A1 gene, doctors use genetic testing, usually with a blood or saliva sample. This is how genetic testing for SLC46A1 variants works: a lab reads the gene’s DNA code and checks for variants, often as part of a multigene panel or exome test.
When should I consider getting a genetic test?
Genetic testing for the SLC46A1 gene may be worth considering if a baby or child has very low folate levels, anemia, poor growth, frequent infections, or developmental delays that suggest trouble absorbing folate from food. It can also help when this condition runs in the family or when both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals varies by the condition and the specific variant. Over time, the way the body works is also shaped by factors such as age, lifestyle, environment, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, it can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It focuses on links between genes and medications to help explain why the same treatment can work differently in different people. For many medicines, genes can influence both how the body handles a medication and how strong its effects are. That information can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SLC46A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so general concerns about your health, supplements, or medicine side effects are best discussed with your doctor. Research on the SLC46A1 gene has looked at how the body handles folate and some folate-blocking medicines, but this has not become standard prescribing guidance.
History
Hereditary folate malabsorption was recognized clinically before the SLC46A1 gene itself was identified, as doctors described infants with poor folate absorption, anemia, and recurrent infections. From these first observations, research expanded steadily. In 2006, researchers linked pathogenic variants in the SLC46A1 gene to this condition, helping explain why some children could not absorb folate normally from the intestine or move enough of it into the brain. This discovery clarified an inherited cause behind a puzzling illness and connected earlier clinical reports to a specific gene. Over time, descriptions became more precise. The finding also helped establish the SLC46A1 gene as the source of the proton coupled folate transporter, an important step in folate genetics.